Saudi Pharmaceutical Industries and Medical Appliances Corp SPIMACO ADDWAEIH SJSC 2070.SR · SAR
Health Care · Tadawul · 🇸🇦 Saudi Arabia
24.55
+1.40%
Close of 9 Nov 2026, in SAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Saudi Pharmaceutical Industries and Medical Appliances Corp SPIMACO ADDWAEIH SJSC
Its shares trade on Tadawul under the ticker 2070.SR. It has been listed since 1 January 1994. In the fiscal year to 31 December 2025, it reported revenue of SAR 1.71bn and net income of SAR 184.4m. At that date it held total assets of SAR 4.37bn and shareholders' equity of SAR 1.60bn.
Saudi Pharmaceutical Industries & Medical Appliances Corp. engages in the development, manufacture and sale of pharmaceutical products and medical appliances. The company is headquartered in Riyadh, Riyadh. The firm is organized, together with its subsidiaries, into two business segments: the Medical and pharmaceutical production segment focuses on the manufacture, production, development and marketing of pharmaceutical raw materials and medical appliances, as well as the production of consumables medical appliances, and the Investment segment is engaged in investing activity in associates and investment in securities. The Company’s product pipeline includes tablets, capsules, dry powder for suspension, syrups and suspensions, injections, creams, ointments and gels, suppositories, mouthwash and antiseptic products. The Company’s manufacturing facility is located at Qassim Industrial City, about 320 kilometers north-west of Riyadh.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 1 Jan 1994
- Website
- spimaco.com.sa ↗
Leadership
Pay as last reported
- Dr. Ahmed Bin Hamdan Al- JedaiNon-Executive Independent Chairman of the BoardSAR 56,556
- Mr. Ammar Bin Abdel Wahid Al-KNon-Executive Independent Vice Chairman of the BoardSAR 230,000
- Mr. Michael BaumChief Executive Financial Officer
- Mr. Atef ZouariExecutive Director of Operations Asset Performance Acting Chief Operating Officer
- Mr. Mohammed AlassmariChief Human Resource Officer
- Dr. Jan- Olav HenkChief Scientific Officer
- Mr. Amjad AliChief Internal Auditor
- Mrs. Ana RuibalChief Developer Officer
- Dr. Maged TahaChief Commercial Officer
- Mr. Khalid Bin Abdulrahman Al-GNon-Executive DirectorSAR 272,000
- Mr. Faisal Bin Mohammed ShakerNon-Executive DirectorSAR 239,000
- Eng. Adel Kareem Kak AhmedNon-Executive DirectorSAR 236,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Headquartered in Riyadh with a manufacturing facility in Qassim Industrial City.
- Operates two business segments: Medical and pharmaceutical production, and Investment.
- Offers a diverse product pipeline including tablets, injections, and medical appliances.
Weaknesses
- No specific weaknesses mentioned in the provided information.
- No details on financial performance or market share provided.
- No information on competitive advantages or unique selling points.
Opportunities
- Potential growth in the pharmaceutical sector in Saudi Arabia.
- Expansion of product offerings within the Medical and pharmaceutical production segment.
- Increased investment opportunities in associates and securities through the Investment segment.
Threats
- No specific threats mentioned in the provided information.
- No details on regulatory challenges or market competition provided.
- No information on economic or political risks affecting the company.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.